✦ LIBER ✦

P0224 A novel, small molecule inhibitor, MSU-1001, in androgen-sensitive prostate cancer cell lines

✍ Scribed by Bhavar, P.K.; Yadav, M.R.; Dinavahi, S.S.; Nyayapathy, S.

Book ID: 125823801
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 38 KB
Volume: 50
Category: Article
ISSN: 0959-8049
DOI: 10.1016/j.ejca.2014.03.268

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

YM155, a Novel Small-Molecule Survivin S

YM155, a Novel Small-Molecule Survivin Suppressant, Combined With Radiation Therapy in Prostate Cancer Cell Lines

✍ Thoms, J.; Aoki, S. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 44 KB

The novel heterodinucleoside dimer 5-FdU

The novel heterodinucleoside dimer 5-FdU-NOAC is a potent cytotoxic drug and a p53-independent inducer of apoptosis in the androgen-independent human prostate cancer cell lines PC-3 and DU-145

✍ R.M.C. Cattaneo-Pangrazzi; H. Schott; R.A. Schwendener 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 323 KB 👁 2 views

BACKGROUND. We analyzed the cytotoxic properties of the new heterodinucleoside phosphate dimer 5-FdU-NOAC, which is composed of the cytotoxic drugs 5-FdU and N 4octadecyl-1-␤-D-arabinofuranosylcytosine (NOAC) against human prostate tumor cells. METHODS. 5-FdU-NOAC effects on cell proliferation, cell